代表性科研成果: . 期刊论文: Wei Yang#, Wan-Ting Zhang#, Ran Zhanga, Wei Wang, Yun Lu, Xian-Jin He, Zi-Dan Zhou, Zhen Jin, Hong-Xia Jiang, Chun-Yuan Li*, Dan Du*, You-Zhi Tang* “4-DMB, a diclofenac derivative, alleviates DSS-induced ulcerative colitis in mice by binding TNFR1 to inhibit inflammation” Biochemical Pharmacology, 2026, Accepted Article 118207. (DOI: 10.1016/j.bcp.2026.118207) Qi Wang#, Xiao-Bao Deng#, Chang-Lei Liu, Jing Zhou, Zhen Jin, Wei Wang*, Dan Du*, You-Zhi Tang* “Discovery of Novel Ibuprofen-1,3,4-thiadiazole Derivatives Attenuating Ulcerative Colitis by Regulating MAPK-mediated Inflammation and Restoring Intestinal Immune Homeostasis” European Journal of Medicinal Chemistry, 2026, 316: Article 119052. (DOI: 10.1016/j.ejmech.2026.119052) Wei Wang#, Xiao Wang#, Zi-Dan Zhou#, Xiao-Bao Deng#, Xue-Wei Luo#, Qi Wang, Guang-Yu Zhang, Zhe Zhang, Zhong-Sheng Li, Xian-Jin He, Zhen Jin, Chen Yang, Dan Du*, You-Zhi Tang* “7,8-Dihydroxyflavone alleviates ulcerative colitis by binding keap1 to activate an slc7a11-dependent inhibition of NF-κB p65 signaling in macrophages” Journal of Advanced Research, 2026, online Article 2771. (DOI:10.1016/j.jare.2026.01.078) Wei Wang#, Xiao-Ying Chen#, Zan-Wei Dong, Zhong-Shen Li, Zhen Jin, Dan Du*, You-Zhi Tang* “Discovery and Optimization of Ester-linked Ibuprofen-Glycine Hybrids as the NF-κB Pathway Inhibitors for the Treatment of ulcerative colitis” Journal of Molecular Structure, 2025, 1346: Article 143198. (DOI:10.1016/j.molstruc.2025.143198) Dingyi Shen, Li Gong, Wei Yang, Jiaqi Luo, Zhen Jin, and Youzhi Tang* “Anti-Inflammatory Mechanisms of Selenium Nanosheets in Ulcerative Colitis: Protein Corona, GP130 Interaction, and Transcriptomic Profile” Advanced Science, 2025, 12(36): Article e01832. (DOI: 10.1002/advs.202501832) Jia-Qi Luo, Ling-Ling Xu, Ke-Xin Xiao, Bing-Yi Lv, Chong-Shuo Zhai, Qi Wang, Wei Yang, Zi-Dan Zhou, Zhen Jin, Wei Wang*, Dan Du*, You-Zhi Tang* “Enhanced anti-inflammatory efficacy of a new piroxicam analogue through the MEK/ERK/NF-κB pathway in vitro and in vivo” International Immunopharmacology, 2025, 161: Article 115100. (DOI: 10.1016/j.intimp.2025.115100) Chao Lin, Zhong-Sheng Li, Zhan-Wei Dong, Xiao-Yi Wu, Min Ye, Ke Li, Zhen Jin, Wei Wang*, You-Zhi Tang* “Discovery and Optimization of Ibuprofen Derivatives as the NF-κB/iNOS Pathway Inhibitors for the Treatment of Ulcerative Colitis” Bioorganic Chemistry, 2025, 161: Article 108506. (DOI: 10.1016/j.bioorg.2025.108506) Yi-Bin Liu, Xia-Yun Chen, Wei Zhang, Bai-Xue Yu, Yi Cen, Meng-Yi Yan, Qian-Qian Liu, You-Zhi Tang*, Shi-Ying Li* “A CXCR4-Targeted Immunomodulatory Nanomedicine for Photodynamic Amplified Immune Checkpoint Blockade Therapy against Breast Cancer” Acta Biomaterialia, 2025, 197: 400-415. (DOI: 10.1016/j.actbio.2025.03.049) Wei Wang, Jia-Qi Luo, Bing-Yi Lv, Zan-Wei Dong, Chong-shuo Zhai, Yu-Han Hu, Zhen Jin, Dan Du*, You-Zhi Tang* “Herbacetin Attenuates Oxidative Stress via Activating Nrf2/HO-1 Signaling Pathway in RAW 264.7 cells and Caenorhabditis elegans” Journal of Food Biochemistry, 2024, 2024: Article 5515410 (DOI: 10.1155/jfbc/5515410)
授权专利: 汤有志,卢佳勋,靳珍,孙永学. 一种白藜芦醇衍生物及其制备方法和应用,中国发明专利,专利证书号:ZL202311698434.9 (2026-09-15) 汤有志,林超,靳珍,王薇. 一种布洛芬衍生物及其制备方法和应用,中国发明专利,专利证书号:ZL202410314670.4 (2026-07-17) 汤有志,吴炜纯,张剑锋,靳珍,王薇. 一种咖啡酸衍生物及其制备方法,中国发明专利,专利证书号:ZL202410514582.9 (2026-06-02) 汤有志,王哲喻,周子丹,靳珍,吴小仪. 一种白藜芦醇亚胺衍生物及其制备方法和应用,中国发明专利,专利证书号:ZL202411601521.2 (2026-04-14) 汤有志,刘雅红,靳珍,王乐,徐子晰. 一种以2-氨基苯巯醇为连接基团截短侧耳素衍生物制备方法和用途,中国发明专利,专利证书号:ZL202210843414.5 (2023-07-11) 汤有志,刘杰,李雅军,靳珍.一种具有1,3,4-恶二唑侧链的截短侧耳素衍生物及制备与应用,中国发明专利,专利证书号:ZL202110434606.6 (2023-06-23) 汤有志,刘雅红,靳珍,王乐,徐子晰. 一种以2-氨基苯巯醇为连接基团截短侧耳素衍生物制备方法和用途,中国发明专利,专利证书号:ZL201811302461.9 (2023-02-03)
获奖情况 汤有志,孙永学,靳珍,王薇,夏锋,方达,杨丽仙,刘伟,叶桂楠,周子轩 饲用二丁基羟基甲苯分散体及植物酚类提取物的开发与应用,2025年中国商业联合会科学技术奖科技进步奖一等奖,证书号:2025J-1-53-R01 刘雅红,孙坚,廖晓萍,曾振灵,于洋,熊文广,方亮星,周宇峰,汤有志,方炳虎,陈冲,杨润时 动物源性耐药菌产生及传播机制研究,2022年度广东省科学技术奖自然科学奖一等奖,证书号:Z03-1-01-R09
|